Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • HPV

Tag: HPV

  • BiotechToday
  • World

Cervical cancer screening task: ASCCP

bioxone August 2, 2021August 1, 2021 1

Ananya Ghosal, MAKAUT(WB) Guidelines of ASCCP The American cancer society (ASC) released the screening guideline for cervical cancer. The guideline initiates a shift in practice to Human papilloma Virus (HPV) screening at the age of 25-65 years in people with the cervix. The American Society for colposcopy and cervical pathology (ASCCP) acknowledges the risk and […]

Read More
  • BiotechToday
  • World

Bridgehead imidazoles warding off cervical cancer

bioxone January 8, 2021January 8, 2021 1

Biswadeep Sen, Amity University Kolkata Every cancerous outline hosts various problems for us, and cervical cancer is no different. But recent studies show that we have indeed found a way to tackle these “slippery opponents” of ours and might be closer to finding a permanent solution. The oncoproteins E6 and E7 of the Human Papillomavirus […]

Read More
  • BiotechToday
  • World

ROLE OF GATA6-AS IN DOWNREGULATING miR-205

bioxone November 14, 2020November 14, 2020 1

Sumedha Guha, Techno India University Uncontrolled cell growth and division unleashed by an alteration (known as ‘mutation’) in the genetic circuits that regulate the cell cycle in a normal cell lead to cancer. In women, cervical cancer is the 2nd most commonly occurring cancer with more than 500,000 cases reported worldwide and 200,000 deaths. Cervical […]

Read More
  • BiotechToday
  • World

Do oncogenic driver mutations cause squamous cell cancers?

bioxone October 9, 2020October 8, 2020

Saptaparna Pal, Amity University Kolkata Head and neck squamous cell carcinoma are one of the most common neoplasias in the world. Most head and neck squamous cell carcinoma are treated as advanced disease and the multidisciplinary treatment strategies include radiotherapy (RT), chemotherapy (CT), surgery, and selected therapy. The addition of cetuximab, an IgGI chimeric monoclonal […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy